Literature DB >> 8137595

Standards for bioequivalence of inhaled products.

H Chrystyn1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8137595     DOI： 10.2165/00003088-199426010-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  28 in total

1.  Use of pressurised aerosols by asthmatic patients.

Authors:  I C Paterson; G K Crompton
Journal:  Br Med J       Date:  1976-01-10

2.  Evaluation of a breath operated powder inhaler.

Authors:  G M Pover; C G Langdon; S R Jones; C Fidler
Journal:  J Int Med Res       Date:  1988 May-Jun       Impact factor: 1.671

3.  Comparison of inhaled salbutamol powder and aerosol in asthmatic patients with low peak expiratory flow level.

Authors:  H Tukiainen; E O Terho
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  How should a pressurized beta-adrenergic bronchodilator be inhaled?

Authors:  S P Newman; D Pavia; S W Clarke
Journal:  Eur J Respir Dis       Date:  1981-02

5.  Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis.

Authors:  S G Spiro; C A Singh; S E Tolfree; M R Partridge; M D Short
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

6.  Problems patients have using pressurized aerosol inhalers.

Authors:  G K Crompton
Journal:  Eur J Respir Dis Suppl       Date:  1982

7.  Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.

Authors:  L Borgström; S Newman; A Weisz; F Morén
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

8.  Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

Authors:  M Hindle; D A Newton; H Chrystyn
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

9.  Effects of various inhalation modes on the deposition of radioactive pressurized aerosols.

Authors:  S P Newman; D Pavia; N Garland; S W Clarke
Journal:  Eur J Respir Dis Suppl       Date:  1982

10.  Influence of age on response to ipratropium and salbutamol in asthma.

Authors:  M I Ullah; G B Newman; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139
View more
  6 in total

1.  Bioinequivalence and drug toxicity. How great is the problem and what can be done?

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

2.  Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.

Authors:  M Hindle; H Chrystyn
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

3.  Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.

Authors:  Federico Lavorini; Pietro Geri; Laura Mariani; Cecilia Marmai; Nazzarena Maria Maluccio; Massimo Pistolesi; Giovanni A Fontana
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

4.  Volumatic usage: some generic salbutamol metered dose inhalers can be used.

Authors:  J K Chege; H Chrystyn
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

Review 5.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

6.  Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.

Authors:  B T van den Berg; R T Louwerse; G J Luiken; R E Jonkers; C J van Boxtel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.